NAPS Global India IPO has received a muted response from investors so far, with the subscription reaching nearly 42 per cent ...

The NAPS Global India IPO launched on March 5, priced at ₹90 per share, with a minimum bid of 1,600 shares. The company, a ...

Notably, the Asian routes dominate the list of the world's busiest domestic and international flight routes in March 2025.

The automaker is aggressively pursuing its global electrification plans, despite slower than anticipated EV adoption and ...

The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...

Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.

Balaji Phosphates IPO allotment will be finalised today, March 5. Investors can check their allotment status on Skyline ...

Yes it shares the same underpinnings as the excellent EV9, but Hyundai’s stately new tech-laden flagship is refined enough to ...

Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of ...

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

Spy shots of vehicles in testing confirm that Genesis’ upcoming GV90 EV will retain the rear suicide doors seen on the ...